Stocks ticked slightly higher in early trading as dropping Treasury yield rates eased pressure on Wall Street. Yesterday’s interest rate induced sell-off sent tech shares plummeting, dragging the Nasdaq down 2.83%. This morning, tech shares were looking to rebound, taking back some of yesterday’s losses.
The pandemic forced us to change the way we go about our day to day in so many ways. The disruption was felt deeply, but some of the changes that resulted have proven to be upgrades. One area where this is the case is education. Our stock pick for today features an education software provider that, through its versatility and broad offerings, stands to benefit significantly from changing education models.
Banyan Hill Publishing:
Just $2 a Share Today — The No. 1 Investment of the 2020s
New technology’s user base growing at 5X the speed of the internet in the 1990s. Could dwarf dot-com boom. [Click here to get details on $2 stock now.]
Since 2016, cloud-based education software provider PowerSchool’s (PWSC) has been helping K-12 schools and universities operate, manage and track everything from admissions, attendance, and homework and to offer online platforms, student counseling, career counseling, and teacher support.
PWSC stock has seen considerable gains since its July 28th IPO. The company’s initial public offering raised $809 million. After less than two months on the NYSE, PowerSchool closed Friday with a market capitalization of $6.09 billion. PWSC shares began trading at $18, peaked as high as $35.88 (after positive feedback from the analyst community), and has since dropped to around $25.25.
The company recently reported Q2 earnings that were generally in line with consensus estimates. Still, its revenues indicate strong demand that is expected to continue as schools reopen, and students return to the classroom. Revenue was up 41% year-over-year.
“The demand for our unified solutions that help accelerate learning outcomes and improve school operations is demonstrated by continued business momentum driving strong and balanced results in the second quarter,” said Hardeep Gulati, PowerSchool CEO. “We believe our unified solutions are filling that need for our customers and are helping to drive real impact within their communities. The funding environment for K-12 education remains robust and has resulted in continued investments in technology from our school and district customers, and the momentum we are seeing gives us confidence in our ability to deliver on our 2021 and 2022 plans.”
The company’s subscription revenues were up 37.5% year-over-year, showing that existing customers are sticking around and upgrading their purchase packages. Net loss was $2.5 million compared to $12.4 million in the prior-year period, an improvement of 79.5%.
The software firm recently closed a high-profile deal with Miami-Dade County in Florida, underlining its value to major metropolitan school systems. Plus, with 1.3 billion potential students to reach international markets, the long-term prospects seem solid.
PWSC’s market-leading suite of K-12 software applications position it as a proper education platform. Although the stock has seen considerable gains since its IPO, the share price remains at an attractive level. The current consensus among 10 polled analysts is to Buy PWSC stock. There are 7 Buy ratings, 3 Hold ratings, and no Sell ratings. A median 12-month price target of $37.50 represents a 48% upside from its current price.
Where to invest $1,000 right now...
Before you consider buying PowerSchool, you'll want to see this.
Investing legend, Keith Kohl just revealed his #1 stock for 2022...
And it's not PowerSchool.
Jeff Bezos, Peter Thiel, and the Rockefellers are betting a colossal nine figures on this tiny company that trades publicly for $5.
Keith say’s he thinks investors will be able to turn a small $50 stake into $150,000.
Find that to be extraordinary?
Click here to watch his presentation, and decide for yourself...
But you have to act now, because a catalyst coming in a few weeks is set to take this company mainstream... And by then, it could be too late.
Click here to find out the name and ticker of Keith's #1 pick...
New in Biotech:
The Guardian: “New pill could spell the end of all disease.”
This pill is set to completely change the lives of millions of Americans.
And because just one tiny Brisbane company has virtually monopolized this technology with 140 foolproof patents…
Investors who get in on the ground floor stand to become rich beyond their wildest dreams. [Full Story…]